Assay ID | Title | Year | Journal | Article |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID303805 | Effect on T3S in Yersinia pseudotuberculosis 3 pIB29 assessed as inhibition of light emission at 50 uM by luciferase reporter gene assay | 2007 | Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
| Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. |
AID303804 | Effect on T3S in Yersinia pseudotuberculosis 3 pIB29 assessed as inhibition of light emission at 100 uM by luciferase reporter gene assay | 2007 | Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
| Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. |
AID303811 | Effect on T3S in Yersinia pseudotuberculosis 3 pIB29 assessed as inhibition of light emission at 0.5 uM by luciferase reporter gene assay | 2007 | Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
| Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. |
AID303810 | Effect on T3S in Yersinia pseudotuberculosis 3 pIB29 assessed as inhibition of light emission at 1 uM by luciferase reporter gene assay | 2007 | Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
| Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. |
AID303809 | Effect on T3S in Yersinia pseudotuberculosis 3 pIB29 assessed as inhibition of light emission at 2 uM by luciferase reporter gene assay | 2007 | Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
| Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. |
AID303808 | Effect on T3S in Yersinia pseudotuberculosis 3 pIB29 assessed as inhibition of light emission at 5 uM by luciferase reporter gene assay | 2007 | Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
| Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. |
AID303806 | Effect on T3S in Yersinia pseudotuberculosis 3 pIB29 assessed as inhibition of light emission at 20 uM by luciferase reporter gene assay | 2007 | Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
| Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. |
AID303807 | Effect on T3S in Yersinia pseudotuberculosis 3 pIB29 assessed as inhibition of light emission at 10 uM by luciferase reporter gene assay | 2007 | Journal of medicinal chemistry, Nov-29, Volume: 50, Issue:24
| Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |